2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow trofosfamide: new trials by email Literature Review of trofosfamide trials Research Report on trofosfamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma trofosfamide, idarubicin, etoposide - Soft Tissue Sarcoma | Phase 3 | Completed | University Hospital Tuebingen | 195 | 2009-07-01 | 2022-11-08 |
| Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children carboplatin, etoposide, temozolomide - Recurrent Brain Tumors, Supratentorial PNETs | Phase 2 / Phase 3 | Completed | University Hospital, Bonn | 174 | 2006-02-01 | 2018-07-20 |
Brain Neoplasms (1) · Ependymoma (1) · Medulloblastoma (1) · Recurrence (1) · Rhabdomyosarcoma (1) · Sarcoma (1) · Sarcoma, Synovial (1)
University Hospital Tuebingen (1) · University Hospital, Bonn (1)
Germany (2) · Austria (1) · Poland (1) · Sweden (1) · Switzerland (1)
Ewa Koscielniak, MD (1) · Gudrun Fleischhack, MD (1) · Monika Sparber Sauer, MD (1) · Thomas Klingebiel, MD (1)